Hospital
Meridian Hospitals Corporation
Meridian Hospitals Corporation was paid $2.31M by Medicaid between Jan 2018 and Jul 2018, across 124 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoMERIDIAN HOSPITALS CORPORATION
RED BANK, NJ 07701
RED BANK, NJ 07701
33aNPI1336147834assigned 07/08/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.31M
24GClaims35,220
24DCodes billed124
24AFirst – last monthJan 2018 – Jul 2018
Compared with peers
Next to other General Acute Care Hospital providers in New Jersey
Rank by total paid#68 of 93
Median peer was paid$30.60M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,220 | $2.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 1,430 | 1,370 | $446K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 779 | 747 | $315K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.9% | 982 | 950 | $204K |
| G0378 | Hospital observation service, per hour | 6.8% | 162 | 148 | $156K |
| S9480 | Intensive outpatient psychiatric services, per diem | 6.2% | 164 | 155 | $142K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 3.7% | 1,236 | 329 | $86K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.2% | 312 | 302 | $75K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.2% | 689 | 180 | $73K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.8% | 622 | 341 | $64K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.4% | 734 | 176 | $56K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.4% | 1,009 | 860 | $55K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.2% | 824 | 502 | $50K |
112 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 41 | $37K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.5% | 630 | $34K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 618 | $31K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 274 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 2,416 | $26K |
| OP379 | 1.0% | 224 | $24K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 730 | $23K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 357 | $22K |
| 80053 | Comprehensive metabolic panel | <1% | 2,090 | $21K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 149 | $18K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,165 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 325 | $14K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 154 | $13K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 105 | $13K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 220 | $12K |
| 77336 | <1% | 24 | $11K | |
| OP272 | <1% | 307 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 521 | $11K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 94 | $10K |
| OP710 | <1% | 108 | $8K | |
| OP279 | <1% | 291 | $8K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 401 | $8K |
| 90670 | <1% | 28 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 226 | $6K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 160 | $6K |
| 97010 | <1% | 555 | $6K | |
| 92552 | <1% | 85 | $6K | |
| OP259 | <1% | 1,687 | $6K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 122 | $6K |
| 85610 | <1% | 493 | $5K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 165 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 300 | $5K |
| 92567 | <1% | 84 | $5K | |
| 84484 | <1% | 536 | $5K | |
| 80061 | Lipid panel | <1% | 228 | $5K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 313 | $5K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 33 | $5K |
| 71045 | Radiologic examination, chest; single view | <1% | 202 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 254 | $4K |
| 81003 | <1% | 1,288 | $4K | |
| 76642 | <1% | 59 | $4K | |
| 84439 | <1% | 154 | $4K | |
| 85730 | <1% | 431 | $4K | |
| 76801 | <1% | 30 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 63 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 149 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 44 | $3K |
| 83735 | <1% | 158 | $3K | |
| 81025 | <1% | 128 | $3K | |
| 76813 | <1% | 27 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 269 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 54 | $3K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 47 | $3K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 15 | $2K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 60 | $2K |
| 87088 | <1% | 523 | $2K | |
| 93971 | <1% | 13 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 89 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 95 | $2K |
| 88304 | <1% | 50 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 13 | $2K |
| 83690 | <1% | 338 | $2K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 20 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 695 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 18 | $1K |
| 87070 | <1% | 577 | $1K | |
| 86885 | <1% | 148 | $1K | |
| 82607 | <1% | 53 | $1K | |
| 99173 | <1% | 76 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 24 | $1K |
| 86901 | <1% | 207 | $1K | |
| 86900 | <1% | 205 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 40 | $984.48 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 33 | $969.54 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 42 | $962.18 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 42 | $959.01 |
| 97161 | <1% | 12 | $887.51 | |
| 87040 | <1% | 100 | $883.62 | |
| 85027 | <1% | 111 | $847.56 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 88 | $832.18 |
| 72110 | <1% | 27 | $731.01 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 581 | $727.80 |
| 83655 | <1% | 26 | $686.98 | |
| 73030 | <1% | 43 | $682.46 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 108 | $622.05 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $488.30 |
| 73610 | <1% | 52 | $486.15 | |
| G0008 | Administration of influenza virus vaccine | <1% | 12 | $484.54 |
| 73630 | <1% | 31 | $483.70 | |
| 87999 | <1% | 202 | $476.30 | |
| 73130 | <1% | 42 | $342.71 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 44 | $341.21 |
| 83789 | <1% | 57 | $316.85 | |
| 90715 | <1% | 14 | $310.82 | |
| 84703 | <1% | 71 | $291.01 | |
| 83880 | <1% | 18 | $218.22 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 24 | $218.03 |
| 73110 | <1% | 12 | $211.11 | |
| 82728 | <1% | 13 | $199.80 | |
| 85651 | <1% | 62 | $143.59 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 12 | $124.15 |
| 84702 | <1% | 16 | $74.07 | |
| 82248 | <1% | 14 | $64.35 | |
| 87147 | <1% | 65 | $63.65 | |
| 85378 | <1% | 48 | $57.04 | |
| 82247 | <1% | 16 | $52.19 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 250 | $46.00 |
| 87186 | <1% | 12 | $44.00 | |
| 86308 | <1% | 43 | $24.65 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 20 | $6.64 |
| 73080 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGANTNER, JOHN (SENIOR VP, FINANCE & CEO)
| Provider | Location | Paid |
|---|---|---|
| Meridian Hospitals Corporation | Neptune, NJ | $11.83M |
| Meridian Hospitals Corporation | Brick, NJ | $4.72M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.